Analysts anticipate for 2024 on revenue increase Astrazeneca, high dividend yield

Tomorrow the English Astrazeneca will publish its past quarters figures. Over the current book year the company from Cambridge's total revenue could be around 52.34 billion GBp (consensus estimates). The expected revenue would be a record for the company. This is hugely more than 2023's revenue of 45.81 billion GBp.

Historical revenues and results Astrazeneca plus estimates 2024

Astrazeneca Nijmegen The Netherlands © Astrazeneca

The analysts expect for 2024 a net profit of 12.51 billion GBp. According to most of the analysts the company will have a profit per share for this book year of 808 GBp. The PE-ratio therefore is 12.26.

Huge dividend Astrazeneca

For this year the analysts expect a dividend of 312 GBp per share. The dividend yield is then 3.15 percent. The average dividend yield of the pharmaceutical companies is a good 2.07 percent.

Astrazeneca 's market capitalization is based on the number of outstanding shares around 15347.67 billion GBp.

Historical stock prices Astrazeneca

On Friday the stock closed at 9903 GBp.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.